Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF.

MLA

Suzuki, Toru, et al. “Association with Outcomes and Response to Treatment of Trimethylamine N-Oxide in Heart Failure: Results from BIOSTAT-CHF.” European Journal of Heart Failure, vol. 21, no. 7, July 2019, pp. 877–86. EBSCOhost, https://doi.org/10.1002/ejhf.1338.

APA

Suzuki, T., Yazaki, Y., Voors, A. A., Jones, D. J. L., Chan, D. C. S., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Hillege, H. L., Lang, C. C., Ponikowski, P., Samani, N. J., van Veldhuisen, D. J., Zannad, F., Zwinderman, A. H., Metra, M., & Ng, L. L. (2019). Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF. European Journal of Heart Failure, 21(7), 877–886. https://doi.org/10.1002/ejhf.1338

Chicago

Suzuki, Toru, Yoshiyuki Yazaki, Adriaan A. Voors, Donald J.L. Jones, Daniel C.S. Chan, Stefan D. Anker, John G. Cleland, et al. 2019. “Association with Outcomes and Response to Treatment of Trimethylamine N-Oxide in Heart Failure: Results from BIOSTAT-CHF.” European Journal of Heart Failure 21 (7): 877–86. doi:10.1002/ejhf.1338.